TBNHealth
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Publication: STAT
Author: Mario Aguilar
Source published: 22/10/2026, 13:17:29 UTC
Briefing created: 22/10/2026, 16:39:54 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 22/10/2026, 16:36:24 UTC.
Briefings
The provided evidence is a newsletter sign-up page from STAT's Health Tech newsletter, dated October 2026, announcing a future article on FDA guidance for drug-related apps. It does not contain the actual findings, dates, or details of the guidance itself.
Key points
- The source is a newsletter sign-up page from STAT's Health Tech newsletter, published on October 22, 2026.
Context
This is a static sign-up page, not a research article or news report containing findings about FDA guidance.
Limitations
No specific dates, numbers, or findings are provided; the content is limited to a sign-up page.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 22/10/2026, 16:39:54 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeid5vbgvvihetr3fxoq565mf5avk4aj5magaylu6c364v25rqzjnuu